Ironwood Pharmaceuticals (IRWD) Cash from Operations (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Cash from Operations data on file, last reported at 5121000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 74.34% year-over-year to 5121000.0; the trailing twelve-month figure through Mar 2026 stood at 112211000.0 (up 42.91% YoY), and the FY2025 full-year result was 127044000.0, up 22.69% from the prior year.
• Cash from Operations eased to 5121000.0 in Q1 2026, from 74575000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 80171000.0 in Q1 2023 to a low of 15068000.0 in Q2 2025.
• A 5-year average of 40759058.82 and a median of 35834000.0 in 2023 frame the typical range for Cash from Operations.
• Peak annual rise in Cash from Operations reached 390.17% in 2025, while the deepest fall reached 145.03% in 2025.
• Tracing IRWD's Cash from Operations over 5 years: stood at 79182000.0 in 2022, then slumped by 54.74% to 35834000.0 in 2023, then tumbled by 57.54% to 15214000.0 in 2024, then surged by 390.17% to 74575000.0 in 2025, then slumped by 93.13% to 5121000.0 in 2026.
• Business Quant data shows IRWD's Cash from Operations at 5121000.0 in Q1 2026, 74575000.0 in Q4 2025, and 47583000.0 in Q3 2025.